181.00
price up icon3.68%   6.42
pre-market  Vorhandelsmarkt:  172.19   -8.81   -4.87%
loading

Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
7.37%
45.25
42.14 8.556 - -
Operating Expenses
33.15%
51.93
39.01 34.55 38.05 48.82
Benefits Costs and Expenses
100.00%
-
37.80 - - -
Costs And Expenses
162.11%
51.93
-83.62 34.55 - -
Operating Income/Loss
313.00%
-6.684
3.138 -25.99 -38.05 -48.82
Income/Loss From Continuing Operations Before Tax
942.39%
45.25
4.341 8.556 -33.21 -45.30
Income/Loss From Continuing Operations After Tax
89.28%
0.932
8.692 80.75 -33.21 -45.30
Net Income/Loss
89.28%
0.932
8.692 80.75 -33.21 -45.30
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
8,176%
28.30
0.3419 28.04 26.66 25.71
Diluted Average Shares
7,875%
29.29
0.3673 28.89 26.66 25.71
Basic Earnings Per Share
90.63%
0.03
0.32 2.88 -1.25 -1.76
Diluted Earnings Per Share
90.32%
0.03
0.31 2.79 -1.25 -1.76
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
Kapitalisierung:     |  Volumen (24h):